Skip to content
Search

Latest Stories

Serious Shortage Protocol for Fluoxetine 30mg capsules expires on July 28

The Serious Shortage Protocol, SSP007 for Fluoxetine 30mg capsules expires at 23.59pm on Wednesday (July 28) as the Department of Health and Social Care (DHSC) has confirmed that sufficient stock is now available to meet normal demand.

DHSC said that any prescriptions for Fluoxetine 30mg capsules must be dispensed in accordance with the prescription, and the SSP012 will no longer be valid for use.


The Pharmaceutical Services Negotiating Committee has advised pharmacy teams to submit their SSP claims using the EPS token if dispensing systems do not support all the endorsement requirements to submit a valid claim.

If a pharmacy is using an EPS token to submit SSP claims, they are reminded to mark the corresponding EPS message as ‘Not Dispensed’ or ’ND’, to avoid double-claiming.

It further advised using the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month.

Any paper prescriptions or EPS tokens with SSP claims need to be placed in the red separator provided by the NHSBSA (and kept separate from other tokens for non-payment i.e. with paid/exempt status).

For any supplies made in accordance with SSPs, pharmacists are asked to check that the correct number of patient charges are collected and declared on the end of month FP34C submission document.

PSNC said, "Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP. For example, for the Fluoxetine 30mg capsules, which expires on 28 July, the NHSBSA would continue to look for the “SSP” or “NCSO” endorsement on prescriptions for Fluoxetine 30mg capsules that are submitted with the July batch (submitted by the 5th of August), August batch (submitted by the 5th September) and September batch (submitted by the 5th of October).

It addedd, "Until 5th October 2021, NHSBSA will accept both the “SSP” and “NCSO” endorsement. For further information on the new endorsement requirements for this SSP."

NHSBSA advise that contractors must follow the specific endorsement guidance issued with each SSP and endorsements should be clear and unambiguous – NHSBSA processing staff must be able to determine what has been supplied.

Pharmacy contractors should keep a record of all SSP claims submitted each month to reconcile against their monthly Schedule of Payments or Prescription Item (Px) reports.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less